Restoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors.
about
Emerging drugs to treat squamous cell carcinomas of the head and neck.Molecular mechanisms contributing to resistance to tyrosine kinase-targeted therapy for non-small cell lung cancer1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells.Use of K-Ras as a predictive biomarker for selecting anti-EGF receptor/pathway treatment.NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia.PTEN and PI3K/AKT in non-small-cell lung cancer.Thymosin alpha 1 suppresses proliferation and induces apoptosis in breast cancer cells through PTEN-mediated inhibition of PI3K/Akt/mTOR signaling pathway.The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line.Long-term exposure of gastrointestinal stromal tumor cells to sunitinib induces epigenetic silencing of the PTEN gene.PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome.Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cells.EGFR-TKIs resistance via EGFR-independent signaling pathways.
P2860
Q35098322-000402E4-1663-473D-86DF-F9B9255F9453Q36814305-2FA62E2C-1742-4155-8F60-E21A1E7C3EC5Q37165972-4451C21C-D767-4D60-BE4E-17018BE22F60Q37779308-B495A03C-C07E-46CB-9458-FAFA948BDA26Q37861191-F789840F-89A4-405E-BBE9-6C6A9DA1344DQ38629644-057C315D-5366-4298-A8C9-28389DF6C535Q38871798-5F6B5D89-048D-4457-A788-F1542F8CA8A0Q38886817-88BE80D0-1CBC-464A-AE1F-BC3DEBD261F2Q39294074-C3D8964C-2692-49D8-870F-E45CE6055E80Q39568926-60849FDC-657E-449C-9D21-2F826BA3908BQ39580327-69B630A1-BF5D-465B-920A-C8FE98BB8783Q39887931-AB114D19-11B5-4320-A976-C25A7ECF38B9Q49887890-AC54977C-5CCA-4858-8E98-57D9EC35CA1B
P2860
Restoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Restoration of PTEN expression ...... ncer cells to EGFR inhibitors.
@ast
Restoration of PTEN expression ...... ncer cells to EGFR inhibitors.
@en
type
label
Restoration of PTEN expression ...... ncer cells to EGFR inhibitors.
@ast
Restoration of PTEN expression ...... ncer cells to EGFR inhibitors.
@en
prefLabel
Restoration of PTEN expression ...... ncer cells to EGFR inhibitors.
@ast
Restoration of PTEN expression ...... ncer cells to EGFR inhibitors.
@en
P2093
P2860
P356
P1433
P1476
Restoration of PTEN expression ...... ncer cells to EGFR inhibitors.
@en
P2093
P2860
P304
P356
10.1002/PROS.20745
P577
2008-06-01T00:00:00Z